Evidence-Based Medicine Guidelines
Clobazam as add-on for refractory epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Clobazam as Add-on for Refractory Epilepsy." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456576/all/Clobazam_as_add_on_for_refractory_epilepsy.
Clobazam as add-on for refractory epilepsy. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/456576/all/Clobazam_as_add_on_for_refractory_epilepsy. Accessed March 11, 2025.
Clobazam as add-on for refractory epilepsy. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/456576/all/Clobazam_as_add_on_for_refractory_epilepsy
Clobazam as Add-on for Refractory Epilepsy [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 11]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456576/all/Clobazam_as_add_on_for_refractory_epilepsy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Clobazam as add-on for refractory epilepsy
ID - 456576
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456576/all/Clobazam_as_add_on_for_refractory_epilepsy
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
